In total, 331,590 bottles of Cinacalcet tablets manufactured by Dr. Reddy's Laboratories, Inc. have been recalled due to potentially harmful levels of nitrosamine.

Cinacalcet is absorbed rapidly from the gastrointestinal tract after oral administration, and the highest drug concentrations in serum are achieved 60 to 90 minutes after single oral doses.

Cinacalcet and etelcalcitide can improve iPTH control, but cinacalcet dosed daily at home is linked to poor adherence rates and etelcalcitide is associated with higher rates of hypocalcemia.

A recent post-marketing study of cinacalcet for patients with secondary hyperparathyroidism on dialysis provides important real-world data. Credit: Getty Images Cinacalcet use does not increase ...

Cinacalcet effectively reduced parathyroid hormone levels independently of disease severity or changes in vitamin D sterol dose. Conclusions.

THOUSAND OAKS, Calif., Aug. 31, 2017 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the European Commission (EC) has granted Marketing A ...

THOUSAND OAKS, Calif., June 23, 2017/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Committee for Medicinal Products for Human Use (C ...

Of 1948 patients on cinacalcet, 938 (48.2%) reached the primary composite end point vs 952 of 1935 (49.2%) in the placebo group. The median duration of study-drug exposure was 21.2 months for ...

Cinacalcet (Sensipar/Mimpara, Amgen), a calcimimetic agent that acts by allosteric activation of the calcium-sensing receptor on parathyroid tissue, was approved for clinical use after its safety ...

Cinacalcet is an effective treatment for secondary hyperparathyroidism in patients on dialysis. Until now, no randomized, placebo-controlled, long-term trial has tested this drug in individuals ...

When the patient developed a recurrent parathyroid adenoma she refused surgery and in this case study the authors describe, for the first time, the use of the calcimimetic cinacalcet in a patient ...